Drug Shortage Report for MYLAN-HYDROXYUREA
Report ID | 3372 |
Drug Identification Number | 02242920 |
Brand name | MYLAN-HYDROXYUREA |
Common or Proper name | HYDROXYUREA |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROXYUREA |
Strength(s) | 500MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-07-21 |
Actual start date | 2017-07-24 |
Estimated end date | 2018-02-26 |
Actual end date | 2018-02-27 |
Shortage status | Resolved |
Updated date | 2018-02-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v49 | 2018-02-28 | English | Compare |
v48 | 2018-02-27 | French | Compare |
v47 | 2018-02-27 | English | Compare |
v46 | 2018-02-23 | French | Compare |
v45 | 2018-02-23 | English | Compare |
v44 | 2018-02-09 | French | Compare |
v43 | 2018-02-09 | English | Compare |
v42 | 2018-02-05 | French | Compare |
v41 | 2018-02-05 | English | Compare |
v40 | 2018-02-02 | French | Compare |
v39 | 2018-02-02 | English | Compare |
v38 | 2018-01-08 | French | Compare |
v37 | 2018-01-08 | English | Compare |
v36 | 2018-01-02 | French | Compare |
v35 | 2018-01-02 | English | Compare |
v34 | 2017-12-30 | English | Compare |
v33 | 2017-12-11 | French | Compare |
v32 | 2017-12-11 | English | Compare |
v31 | 2017-11-29 | French | Compare |
v30 | 2017-11-29 | English | Compare |